These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 6230926)

  • 21. Milrinone and dobutamine in severe heart failure: differing hemodynamic effects and individual patient responsiveness.
    Colucci WS; Wright RF; Jaski BE; Fifer MA; Braunwald E
    Circulation; 1986 Mar; 73(3 Pt 2):III175-83. PubMed ID: 3510774
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of some new positive inotropic agents in guinea pigs.
    van Meel JC
    Pharmacology; 1985; 31(1):1-10. PubMed ID: 3161096
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative acute hemodynamic effects of intravenous sodium nitroprusside and MDL-17,043, a new inotropic drug with vasodilator effects, in refractory congestive heart failure.
    Amin DK; Shah PK; Hulse S; Shellock F
    Am Heart J; 1985 May; 109(5 Pt 1):1006-12. PubMed ID: 3158182
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acute hemodynamic effects of piroximone (MDL 19,205) in patients with moderate congestive heart failure: comparison with sodium nitroprusside.
    Arbogast R; Brandt CM; Fincker JL; Schechter PJ
    J Cardiovasc Pharmacol; 1986; 8(1):82-9. PubMed ID: 2419699
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Myocardial energetics and clinical response to the cardiotonic agent MDL 17043 in advanced heart failure.
    Martin JL; Likoff MJ; Janicki JS; Laskey WK; Hirshfeld JW; Weber KT
    J Am Coll Cardiol; 1984 Nov; 4(5):875-83. PubMed ID: 6238075
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Dose-response relation of intravenous enoximone in congestive cardiac insufficiency].
    Lellouche D; Delorme G; Merlet P; Dubois-Randé JL; Duval AM; Tarral A; Bourdarias JP; Vernant P
    Arch Mal Coeur Vaiss; 1988 Sep; 81(9):1107-13. PubMed ID: 2973777
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The acute hemodynamic effects of a new agent, MDL 17,043, in the treatment of congestive heart failure.
    Uretsky BF; Generalovich T; Reddy PS; Spangenberg RB; Follansbee WP
    Circulation; 1983 Apr; 67(4):823-8. PubMed ID: 6218939
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hemodynamic and clinical evaluation of piroximone, a new inotrope-vasodilator agent, in severe congestive heart failure.
    Axelrod RJ; De Marco T; Dae M; Botvinick EH; Chatterjee K
    J Am Coll Cardiol; 1987 May; 9(5):1124-30. PubMed ID: 3571752
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison between the positive inotropic effects of enoximone, a cardiac phosphodiesterase III inhibitor, and dobutamine in patients with moderate to severe congestive heart failure. A study using the end-systolic pressure-volume relationship method.
    Installe E; De Coster P; Gonzalez M; Brichant C; Lessire H; Cauwe F
    Eur Heart J; 1991 Sep; 12(9):985-93. PubMed ID: 1834466
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relative contribution of inotropic and vasodilator effects to amrinone-induced hemodynamic improvement in congestive heart failure.
    Konstam MA; Cohen SR; Weiland DS; Martin TT; Das D; Isner JM; Salem DN
    Am J Cardiol; 1986 Feb; 57(4):242-8. PubMed ID: 3004184
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cardiovascular properties of a new cardiotonic agent: MDL 17,043 (1.3-dihydro-4-methyl-5-[4-(methylthio)-benzoyl]-2H-imidazol-2-one).
    Dage RC; Roebel LE; Hsieh CP; Weiner DL; Woodward JK
    J Cardiovasc Pharmacol; 1982; 4(3):500-8. PubMed ID: 6177949
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Hemodynamic effects of ARL 115 in left ventricular insufficiency].
    Drobinski G; Komajda M; Lechat P
    Ann Cardiol Angeiol (Paris); 1984 Nov; 33(7):475-9. PubMed ID: 6508198
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Role of the enoximone-dobutamine combination in the treatment of congestive cardiac insufficiency].
    Richard C; Thuillez C; Annane D; Bellissant E; Teboul JL
    Arch Mal Coeur Vaiss; 1990 Sep; 83 Spec No 3():33-7. PubMed ID: 2147832
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Low-dose enoximone in subjects awaiting cardiac transplantation. Clinical results and effects on beta-adrenergic receptors.
    Lee HR; Hershberger RE; Port JD; Rasmussen R; Renlund DG; O'Connell JB; Gilbert EM; Mealey PC; Volkman K; Menlove R
    J Thorac Cardiovasc Surg; 1991 Aug; 102(2):246-58. PubMed ID: 1650867
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Amelioration of heart failure by MDL 17043 and MDL 19205, novel positive inotropic drugs, in dog heart-lung preparations.
    Goto T; Nunoki K; Satoh K; Taira N
    Jpn Heart J; 1985 Nov; 26(6):1011-8. PubMed ID: 2937939
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inotropic therapy for refractory congestive heart failure with oral fenoximone (MDL-17,043): poor long-term results despite early hemodynamic and clinical improvement.
    Shah PK; Amin DK; Hulse S; Shellock F; Swan HJ
    Circulation; 1985 Feb; 71(2):326-31. PubMed ID: 3155500
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Positive inotropic and vasodilator actions of milrinone in patients with severe congestive heart failure. Dose-response relationships and comparison to nitroprusside.
    Jaski BE; Fifer MA; Wright RF; Braunwald E; Colucci WS
    J Clin Invest; 1985 Feb; 75(2):643-9. PubMed ID: 3973022
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cardiac energetics after intravenous enoximone in idiopathic dilated cardiomyopathy.
    Heiss HW; Hasenfuss G; Holubarsch C; Meinertz T; Just H
    Am J Cardiol; 1987 Aug; 60(5):53C-56C. PubMed ID: 2956869
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Enoximone/dobutamine comparison in chronic congestive cardiac insufficiency with low cardiac output].
    Galinier M; Rochiccioli JP; Edouard P; Fourcade J; Massabuau P; Puel J; Fauvel JM; Bounhoure JP
    Arch Mal Coeur Vaiss; 1990 Sep; 83 Spec No 3():27-32. PubMed ID: 2147831
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dose-related hemodynamic and electrocardiographic effects of the calcium promoter BAY y 5959 in the presence or absence of congestive heart failure.
    Rousseau MF; Massart PE; van Eyll C; Etienne J; Ahn S; Schaefer HG; Mueck W; Bornemann M; Pouleur H
    J Am Coll Cardiol; 1997 Dec; 30(7):1751-7. PubMed ID: 9385903
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.